CRSP
CRISPR Therapeutics AG
Set alert
51.42 USD -2.84 -5.23%
50.60 Day range 54.10
44.34 52-week range 63.99
- YTD
- -1.95%
- 1 year
- -15.84%
- Open
- 53.27
- Prev close
- 54.26
- Mkt cap
- 4.97B
- Vol
- 1.17M
- Avg vol
- 1.53M
- EPS
- -4.74
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 50.60
- High
- 54.10
- Forward P/E
- -14.25
- Beta
- 1.76
- Short ratio
- 9.18
- Inst. own
- 77.98%
- Dividend
- 0.00
- Ex-div date
- Earnings
- Nov 9, 2026
- 50-d avg
- 54.32
- 200-d avg
- 52.91
- 1y target
- 85.63
1Y chart
Closing price and volume
Compare CRSP
Chart and line up CRSP against other symbols or a saved comparison set.
- CRSP CRISPR Therapeutics AG
51.42
-2.84 -5.23%
- SPY State Street SPDR S&P 500 ETF Trust
755.72
-13.64 -1.77%
- QQQ Invesco QQQ Trust
690.49
-24.85 -3.47%
Sign in to keep these symbols in a saved comparison set.
| Metric | CRSP | SPY | QQQ |
|---|---|---|---|
| Last price | 51.42 | 755.72 | 690.49 |
| Change | -2.84 | -13.64 | -24.85 |
| Change % | -5.23% | -1.77% | -3.47% |
| Open | 53.27 | 761.38 | 697.13 |
| Day high | 54.10 | 761.46 | 698.63 |
| Day low | 50.60 | 750.36 | 683.45 |
| Previous close | 54.26 | 769.36 | 715.34 |
| Volume | 1.17M | 77.70M | 85.24M |
| Average volume | 1.53M | 41.22M | 34.57M |
| Market cap | 4.97B | 812.08B | 483.28B |
| P/E ratio | 0.00 | 23.99 | 26.44 |
| Earnings per share | -4.74 | 31.50 | 26.12 |
| Dividend yield | 0.00 | 0.00 | 0.00 |
| 52-week high | 63.99 | 779.09 | 759.66 |
| 52-week low | 44.34 | 631.97 | 558.28 |
| 1-week return | +4.11% | -0.559233% | -1.97% |
| 1-month return | -7.05% | -0.906075% | -6.66% |
| 3-month return | +6.15% | +1.89% | +1.02% |
| 6-month return | -1.76% | +5.16% | +3.41% |
| Year-to-date return | -1.95% | +10.82% | +12.40% |
| 1-year return | -15.84% | +11.16% | +10.29% |
| 2-year return | +10.84% | +32.90% | +42.71% |
| 50-day moving average | 54.32 | 767.63 | 725.41 |
| 200-day moving average | 52.91 | 728.53 | 679.17 |
| Target price | 85.63 | — | — |
| Beta | 1.76 | 0.00 | 0.00 |
| Short ratio | 9.18 | — | — |
| Institutional ownership | 77.98% | — | — |